Europe — EMA

Onavuo (Dimethyl Fumarate)

Dimethyl fumarate, the active ingredient in Onavuo, is a oral medication presented as a tablet for oral use. It is used in the management of certain chronic skin conditions, primarily psoriasis.

Dimethyl Fumarate

Request sourcing

Pack/s

What is Dimethyl Fumarate?

Dimethyl fumarate, the active ingredient in Onavuo, is a oral medication presented as a tablet for oral use. It is used in the management of certain chronic skin conditions, primarily psoriasis. GNH USA supplies Onavuo as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

GNH USA supplies Onavuo as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

What is Dimethyl Fumarate used for?

Onavuo contains dimethyl fumarate, which acts on inflammatory pathways associated with skin cell proliferation.

- Psoriasis: Reduces scaling, erythema and plaque thickness. - Multiple Sclerosis: Lowers relapse frequency and slows disease progression. - Relapsing‑remitting multiple sclerosis: Provides disease‑modifying treatment. - Chronic dermatitis: Enhances

What are the side effects of Dimethyl Fumarate?

Common

Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Send a sourcing enquiry for this product →